Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2000
11/02/2000EP0808312B1 Indole derivatives as 5-ht receptor antagonist
11/02/2000DE19919218A1 New peptide compounds, e.g. aza-heterocyclic substituted beta-alanine derivatives, are integrin receptor antagonists useful e.g. for treating atherosclerosis, cancer, osteoporosis, hypertension or inflammation
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000CA2368205A1 N-protected amines and their use as prodrugs
11/01/2000CN1272108A Indole derivatives as 5-HT1B and 5-HT1D agonists
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
10/2000
10/31/2000US6140509 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140351 Ortho-anthranilamide derivatives as anti-coagulants
10/31/2000US6140349 Cyclic amine modulators of chemokine receptor activity
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140338 For treating acute inflammatory diseases, chronic inflammatory diseases, acquired immune deficiency syndrome, cancer, ischemic reflow disorder and/or arteriosclerosis
10/31/2000US6140331 For treating anxiety disorders, depression, psychosis, impulse control disorders, alcohol abuse, ischaemic diseases, cardiovascular disorders, side effects induced by conventional antipsychotic agents and senile dementia
10/31/2000US6140322 For therapy or prophylaxis of hypoxia, such as in cases of cardiac arrest, stroke and neonatal hypoxia, neurodegenerative conditions including nerve degeneration and/or nerve necrosis in disorders such as ischaemia, epilepsy, hypoglycemia
10/31/2000US6140273 Herbicides; made by reacting a cyclohexane-1,3-dione with an activated benzoic acid or benzoic acid compound, to give an acylation product, and subsequent rearrangement
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063203A1 Piperidine-indole compounds having 5-ht6 affinity
10/26/2000WO2000063195A1 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors
10/26/2000WO2000063166A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062765A2 ESTROGEN RECEPTOR-β LIGANDS
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000WO2000035865A3 Tubulin-binding agents
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370126A1 Estrogen receptor-.beta. ligands
10/25/2000EP1045846A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors
10/25/2000CN1270958A Beta-lactan
10/25/2000CN1057762C Substituted azadioxacycloalkens use as fungicides
10/24/2000US6136844 5-aroylpyrrol-2-ylmethylarene derivatives
10/24/2000US6136843 Indole derivatives useful as endothelin receptor antagonists
10/24/2000US6136826 Aminopiperidine compounds substituted with alkanoyl
10/24/2000US6136825 Sulfonamide compounds having 5-HT receptor activity
10/24/2000US6136819 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
10/24/2000US6136755 Pyrazole derivatives
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
10/19/2000WO2000061561A1 Cyanoguanidine compounds
10/19/2000WO2000061558A1 Remedies for neuropathic pain
10/19/2000WO2000061557A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000007996A8 Pyrazoles as estrogen receptor modulators
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
10/19/2000CA2369695A1 Agent for treating neuropathic pain
10/19/2000CA2369691A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000CA2368049A1 Integrin receptor ligands
10/18/2000EP1044973A2 Process for the dehalogenation of thiochroman and dihydrobenzothiophene derivatives
10/18/2000EP1044970A1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044191A2 Benzylidene pyrazolones, production and use thereof
10/18/2000EP0773965B1 Gas phase production of polydienes
10/18/2000CN1270583A Substituted phenyluracils
10/18/2000CN1270581A 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
10/18/2000CN1270518A Therapeutic or prophylactic agent for glomerulopathy
10/18/2000CN1270169A Benzopyrane derivatives and preparation thereof
10/17/2000US6133458 Benzo[B]indeno[2, 1-D]thiophene compounds, intermediates, compositions, and methods
10/17/2000US6133303 Various indene derivatives, with the exception of 5-(2-imidazole-1-yl-ethoxy)indan-1-one; treating cancer and treating or preventing restenosis or atherosclerosis
10/17/2000US6133296 Substituted pyridyl keto enols
10/17/2000US6133279 Therapeutic agents for renal diseases and organ preservatives
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133268 1,4-disubstituted piperazines
10/17/2000US6133262 3-aminobenzo(b)thiophene derivatives
10/17/2000US6133252 Fungicides for the control of take-all disease of plants
10/17/2000US6132703 Cosmetic and pharmaceutical preparations containing photostable UV filters
10/17/2000US6132475 For oxidation dyeing of keratin fibers; includes coupler and developer, in which the developer is a substituted 2-(furyl, thienyl, pyrrolyl, or selenophene) p-diaminobenzene derivative of given formula; colorfastness, washfastness
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/17/2000CA2022484C 1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
10/15/2000CA2305940A1 Aminotriazol compounds, the process for preparing them and the pharmaceutical compositions containing them
10/12/2000WO2000059905A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
10/12/2000WO2000059902A2 Aryl sulfonyls as factor xa inhibitors
10/12/2000WO2000059899A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/12/2000WO2000059898A2 Process for the dehalogenation of thiochroman and dihydrobenzothiophene derivatives
10/12/2000WO2000059895A1 Pesticidal tetrazole derivatives
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059498A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369557A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of gabaa receptors
10/12/2000CA2369541A1 Pesticidal tetrazole derivatives
10/12/2000CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
10/12/2000CA2368630A1 Aryl sulfonyls as factor xa inhibitors
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2334478A1 Process for the dehalogenation of thiochroman and dihydrobenzothiophene derivatives
1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 523